Group 1 - The core point of the article highlights the performance and holdings of the ICBC Frontier Medical Stock C fund, which has a latest net value of 2.9480 yuan, reflecting a decrease of 1.54% [1] - The fund's one-month return is 2.47%, ranking 550 out of 932 in its category; the six-month return is 13.21%, ranking 130 out of 909; and the year-to-date return is 14.80%, ranking 127 out of 910 [1] - The top ten stock holdings of the fund account for a total of 59.05%, with significant positions in companies such as Heng Rui Pharmaceutical (10.11%), Kelun Pharmaceutical (8.01%), and WuXi AppTec (7.72%) [1] Group 2 - The ICBC Frontier Medical Stock C fund was established on November 23, 2020, and as of March 31, 2025, it has a total scale of 1.38 billion yuan [1] - Zhao Bei serves as the fund manager and has extensive experience in the healthcare sector, having held various positions within ICBC Credit Suisse Asset Management since 2010 [2]
6月26日工银前沿医疗股票C净值下跌1.54%，近1个月累计上涨2.47%
Sou Hu Cai Jing·2025-06-26 13:00